>
Fa   |   Ar   |   En
   Sorafenib-induced pancreatitis  
   
نویسنده Ayyildiz Talat ,Aydin Taner ,Eminler Ahmet Tarik ,Yildirim Cinar ,Irak Kader ,Kiyici Murat ,Gurel Selim ,Nak Selim Giray ,Gulten Macit ,Dolar Enver
منبع journal of experimental and clinical medicine - 2015 - دوره : 32 - شماره : 3 - صفحه:133 -135
چکیده    Sorafenib is an inhibitor of multikinase proteins which is used for metastaticrenal cell carcinoma and advanced stage hepatocellular carcinoma. its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. five cases of acute pancreatitis have been reported in literature until date. the case we described here is the sixth case of clinically diagnosed acute pancreatitis.
کلیدواژه Hepatocellular carcinoma ,Pancreatitis ,Sorafenib ,Tyrosine kinase inhibitor
آدرس Ondokuz Mayis University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Internal Medicine, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved